Bone Calcium Research Articles

Effect of coated calcium feeding on growth performance, carcass traits, immunity, blood biochemistry and tibial bone morphometry in commercial broiler chicken.

The bone abnormalities pose great concern in heavy, rapidly growing broilers, resulting in significant economic loss, and health issues in birds. To address these problems and prevent unnecessary mineral excretion into environment, it is crucial to optimise the inclusion level of dietary calcium in broiler's diet. The calcium utilisation by the bird is also affected by its source, particle size, bioavailability etc. Hence this study aimed to study the effect of partially replacing conventional dietary calcium source with coated calcium on growth performance, immune response, carcass traits, blood calcium and phosphorus, and mineral retention in broilers. About 416 broiler chicks were randomly distributed into four treatments, each with eight replicates of 13 birds and fed with iso-calcium, isocaloric, and isonitrogenous diet for 42 days. The T0 (control) was a basal diet while the T1, T2, and T3, were treatment diets in which conventional calcium source (limestone) was partially replaced with coated calcium by 10, 20, and 30% respectively. The birds of T3 group showed higher (P < 0.05) body weight gain, better feed conversion ratio and higher carcass yields compared to T0, T1, and T2 diet fed birds. Further the treatment groups exhibited higher (P < 0.05) cell-mediated and humoral immune responses and immune organ weights compared to control. The tibial bone weight, length and average diameter was highest (P < 0.05) in T3. Moreover, the T3 diet fed group also showed higher (P < 0.05) calcium and phosphorus content in serum and bone and lowest content of these minerals in the excreta followed by T2, T1 and control. These findings suggest that a 30% conventional calcium source with coated calcium may be used as a high-grade mineral source for broiler chicken feed.

Dietary superdosing of phytase positively affects growth, mineral utilization and amino acid availability of channel catfish (Ictalurus punctatus)

The present study investigated the effects of supplementing high levels (superdosing) of dietary phytase on growth performance, mineral utilization and digestibility of amino acids in different regions of the gastrointestinal (GI) tract of fingerling channel catfish. The negative control (NC) diet was formulated with primarily soybean meal as a protein feedstuff which contributed 0.61 % total phosphorus (P) but was deficient in available P at 0.11 % of diet. Five other diets were formulated either with supplemental monocalcium phosphate at 1 % of diet in the positive control (PC), or supplemented with Quantum Blue phytase (AB Vista, Plantation, Florida) at 1000, 2000, 4000, or 8000 phytase units (FTU)/kg of diet. Groups of 20 catfish were each stocked into 24 aquaria operated as a closed, recirculating system with biological and mechanical filtration. All dietary treatments were assigned randomly to quadruplicate aquaria and initially fed at 6 % of total body weight per day. Feed quantities were adjusted weekly after weighing all fish in each aquarium as a group, and feeding levels were maintained close to apparent satiation throughout the 8-week feeding trial. Phytase supplementation significantly (P < 0.05) increased various responses of channel catfish including weight gain, feed efficiency, and protein retention compared to catfish fed the NC diet, resulting in values that were similar to catfish fed the PC diet. Moreover, catfish fed the phytase-supplemented diets had higher bone ash, calcium (Ca), magnesium (Mg), P, manganese (Mn), and zinc (Zn), as well as retention of Ca, Mg, P, iron (Fe), Mn, and Zn in whole-body tissues. Additionally, apparent availability of P from the posterior intestinal region increased with dietary phytase supplementation, with reduced excretion of nitrogen, Ca, Mg, P, copper (Cu), Mn, and Zn observed in comparison to fish fed the NC diet. Apparent digestibility coefficients for many of the indispensable and dispensable amino acids were increased by phytase supplementation, except for histidine, methionine, threonine, and taurine. This improvement in amino acid availability occurred only in the posterior region of the gastrointestinal tract. Channel catfish fed the diet containing 4000 FTU/kg diet had the highest postprandial plasma phosphorus level most of the time, except at 24 h after feeding. Based on these various responses, the optimal dietary phytase dosage was determined to average 5492 FTU/kg diet.

Denosumab for Management of Hypercalcemia in Primary Hyperparathyroidism.

Denosumab is a completely human monoclonal high-affinity antibody that binds to the nuclear factor kappa-B ligand (RANKL) and is widely used to treat osteoporosis. Furthermore, it can potentially lower serum calcium levels by inhibiting osteoclast activation and preventing bone calcium from being released into the blood. This review aimed to provide evidence of the efficacy and safety of denosumab in treating hypercalcemia in primary hyperparathyroidism (PHPT). PubMed and the Cochrane Library were searched for published studies that described denosumab for hypercalcemia management in PHPT. Data were extracted by two independent investigators and analyzed using SPSS 23. The risk of bias was assessed by NIH Quality Assessment Tool. In total, 161 patients with PHPT from 18 studies were included in this review. The average age was 61 (47-72) years and the highest serum calcium was 3.76 (3.11-4.20) mmol/l. We found that denosumab can effectively reduce the serum calcium level by a median reduction of 0.5 mmol/l within 3 days. Significant reduction was maintained for 14 days. The serum calcium-lowering effect weakened after one month. In conclusion, denosumab has a potential clinical value in treating hypercalcemia in patients with PHPT.

The effect of empagliflozin (sodium-glucose cotransporter-2 inhibitor) on osteoporosis and glycemic parameters in patients with type 2 diabetes: a quasi-experimental study.

Diabetic osteoporosis (DOP) is a metabolic disease that occurs in patients with diabetes due to insufficient insulin secretion. This condition can lead to sensory neuropathy, nephropathy, retinopathy, and hypoglycemic events, which can increase the risk of fractures. This study aimed to assess the effectiveness of Empagliflozin, a sodium-glucose cotransporter-2 (SGLT-2) inhibitor, in treating diabetic osteoporosis (DOP) and preventing fractures. This quasi-experimental study enrolled 100 patients with diabetic osteoporosis from February 2023 to February 2024. Participants were randomly assigned to an intervention group (n = 50) and a control group (n = 50). The intervention group received Empagliflozin in combination with symptomatic treatment, while the control group received only symptomatic treatment. The treatment duration was six months. Fasting blood glucose (FBG), 2-hour postprandial blood glucose (2h PG), glycosylated hemoglobin A1c (Hb A1c), bone mineral density (BMD), serum phosphorus and calcium concentration were measured after the intervention and the incidence of fracture was followed up for 12 months. The data were analyzed using SPSS 23. Descriptive statistics (mean, standard deviation, and percentage) and analytical methods (t test, Chi square) were also used to analyze the data. After six months of treatment, the intervention group exhibited significantly lower levels of FBG (P < 0.001), 2h-PG (P = 0.001), and HbA1c (P < 0.001) than the control group. Additionally, bone mineral density, serum phosphorus, and calcium levels were significantly higher in the intervention group (P < 0.001). After a 12-months follow-up, the incidence of fractures in the intervention group was 2%, while it was 16.33% in the control group (P < 0.05). Empagliflozin, when combined with symptomatic treatment, demonstrates a positive clinical effect in patients with diabetic osteoporosis. The treatment effectively improves blood glucose metabolism, bone mineral density, and phosphorus and calcium metabolism, ultimately leading to a significant reduction in the incidence of fracture.

Tissue-Engineered Bone Regeneration for Medium-to-Large Osteonecrosis of the Femoral Head in the Weight-Bearing Portion: An Observational Study.

Stem cell therapy for the treatment of osteonecrosis of the femoral head (ONFH) showed promising outcomes. However, ONFH with a large lesion in the weight-bearing portion is a poor prognostic factor and still challenging issue to be solved. We aimed to evaluate the effect of tissue-engineered bone regeneration for this challenging condition to preserve the femoral head. A total of 7 patients (9 hips) with ONFH who received osteoblasts expanded ex vivo from bone marrow-derived mesenchymal stem cells (BMdMSCs) and calcium metaphosphate (CMP) as scaffolds from March 2002 to March 2004 were retrospectively reviewed. The median age was 27.0 years (interquartile range [IQR], 23.0-34.0 years), and the median follow-up period was 20.0 years (IQR, 11.0-20.0 years). After culture and expansion of stem cells, we performed core decompression with BMdMSC implantation at a median number of 10.1 ×107 (IQR, 9.9-10.9 ×107). To evaluate radiographic outcomes, the Association Research Circulation Osseous (ARCO) classifications, the Japanese Investigation Committee (JIC) classification, and modified Kerboul combined necrotic angle (mKCNA) were evaluated preoperatively and during follow-up. Clinical outcomes were evaluated by a visual analog scale (VAS) and Harris Hip Score (HHS). The preoperative stage of ONFH was ARCO 2 in 5 hips and ARCO 3a in 4 hips. The ARCO staging was maintained in 3 hips of ARCO 2 and 4 hips of ARCO 3a. Two hips of ARCO 2 with radiographic progression underwent total hip arthroplasty. According to mKCNA, 2 hips showed medium lesions, and 7 hips showed large lesions. The size of necrotic lesion was decreased in 4 hips (2 were ARCO 2 and 2 were ARCO 3a). There were no significant changes in JIC classification in all hips (type C1: 3 hips and type C2: 6 hips) (p = 0.655). Clinically, there were no significant changes in the VAS and HHS between preoperative and last follow-up (p = 0.072 and p = 0.635, respectively). Tissue engineering technique using osteoblasts expanded ex vivo from BMdMSC and CMP showed promising outcomes for the treatment of pre-collapsed and early-collapsed stage ONFH with medium-to-large size, mainly located in weight-bearing areas.

Memory T-Cells Contribute to Calcium Release from Bones during Lactation in Mice

Objective: Milk production during lactation places a high demand for calcium that is fulfilled both from maternal bone resorption and diet. While it is known that mammary gland-derived PTHrP drives bone resorption during lactation, the impact of postpartum estrogen loss on bone has been unclear. Methods: We used a case-control study design to test the effect of estrogen loss in lactating mice. Results: In the present study, we show for the first time that estrogen loss during lactation activates memory T-cells (TM) to produce TNFα and IL-17A to aid in bone resorption and calcium release. Our studies reveal a new mechanism for the release of calcium from bone postpartum. The findings provide several new insights. First, the immune system plays a critical role in milk production postpartum. Second, evolutionarily, the pathway serves the physiological purpose of increasing bone resorption to release calcium for breastmilk production postpartum but becomes maladaptive postmenopause, leading to osteoporosis. Finally, these results highlight the crosstalk between the brain–bone–breast–endocrine axis and the immune system during lactation.

430 Spent hemp biomass increases bone mineral density in broilers

Abstract Spent hemp biomass (SHB) is a byproduct of CBD oil production, which has been used in multiple trials recently as an alternative feed for livestock, but it has not been approved as a feed ingredient by the FDA-CVM. This is due in part to the lack of information on the potential effects on animal health. Recent studies have shown possible effects of cannabinoids on bone healing, though the effects on bone growth and calcification are not well established. The objective of the study was to investigate the effects of varying levels of SHB on bone growth, calcification, and strength. A total of two hundred birds (5-d-old Cobb 500 Cornish Cross chicks) were randomly assigned to five different rooms with 4 pens per room and 10 animals/pen. Birds received isonitrogenous, isocaloric diets with either 0, 5, 10, or 20% SHB until euthanasia at 42 d. The tibiotarsus, femur, and humerus were collected from 2 males and 2 females per pen for 80 birds (20 per treatment group). The tibiotarsus bending strength was measured with an Instron 5969 using a three-point bending testing fixture set at 10 mm/min for 19 parameters of the bending and breaking properties. The humerus and femur were scanned with a Hologic Discovery A (S/N 84870) DEXA for mineral content (BMC) and density (BMD). Statistical significance was set at P ≤ 0.05 and analyzed using a generalized linear mixed model. BMD and BMC were not affected by treatments in the humerus, a pneumatic bone, but in the weight bearing femur bones, a significant effect on both BMD (P = 0.0078) and BMC (P = 0.0069) was observed. The change in BMC was quadratic, with a peak in animals receiving 10% SHB in the diet, but the BMD effect was linear with the increased dose of SHB in the diet. In the tibiotarsus three-point bending analysis, no significant changes were found in any of the strength and bending parameters measured, except a tendency (P = 0.07) for a greater work-to-fracture adjusted by bone diameter in 5% vs. 0% SHB group. These data indicate some interaction of SHB on the mineralization of bone; however, the level causes less than significant changes to the overall strength of the bone.

P162 THE CORRELATION BETWEEN VITAMIN D WITH ARTERIAL HYPERTENSION, ARTERIAL STIFFNESS AND CORONARY CALCIUM SCORE

Background Introduction: Vitamin D plays significant role in calcium metabolism and in bone and vascular calcifications. Objective: To investigate the association between vitamin D level, arterial hypertension, arterial stiffness and coronary calcifications detected by MSCT. Method: A 2 female case report comparative to each other investigated the correlation between vitamin D serum level, blood pressure, arterial stiffness and severity of the coronary calcification using MSCT diagnostic tool estimating the calcium score. Results: The first case report showed that decreased level of vitamin D is correlated with increased blood pressure, increased arterial stiffness and with a severe coronary calcifications. The second case report showed normal blood pressure, normal vascular age and low calcium score in a no-defficient vitamin D female. Conclusion: Vitamin D has impact on blood pressure, arterial stiffness, coronary calcifications and coronary heart disease. The lower vitamin D, the higher arterial blood pressure, arterial stiffness and coronary calcium score.

Loss of ZC4H2, an Arthrogryposis Multiplex Congenita Associated Gene, Promotes Osteoclastogenesis in Mice.

ZC4H2 encodes a C4H2-type zinc finger protein, mutations of which lead to a spectrum of diseases known as ZC4H2 associated rare disorders (ZARD). In addition to neurological phenotypes, the most typical symptoms of ZARD are multiple joint contractures of varying degrees, accompanied by abnormal development of muscles and bones, and osteoporosis in some cases. The pathogenic mechanisms of such bone related phenotypes, however, remain unclear. Here, we showed that ZC4H2 is expressed in the developing bones in mice. ZC4H2 knockout mice were neonatal-lethal and smaller in size, with reduced calcification of long bones. Upon induced loss of ZC4H2 postnatally, the femoral bones developed an osteoporosis-like phenotype, with reduced bone mineral density, bone-volume fraction, and trabecular bone number. Knockdown of ZC4H2 showed no clear effect on the expression of osteogenic differentiation genes in in vitro models using mesenchymal stem cells. Interestingly, ZC4H2 knockdown significantly enhanced osteoclast differentiation and bone resorption in induced bone marrow-derived macrophages. We further confirmed that the number of osteoclasts in the long bone of ZC4H2 knockout mice was increased, as well as the expression of the serum bone resorption/osteoporosis marker CTX-1. Our study unveils a new role of ZC4H2 in osteoclast differentiation and bone development, providing new clues on the pathology of ZARD.

Transcriptome analysis to explore the mechanism of downregulated TNIK influencing the effect of risperidone.

Risperidone is one of the most reliable and effective antipsychotics for schizophrenia treatment. However, the mechanism of action of risperidone is not yet fully understood. Traf2 and Nck-interacting protein kinase (TNIK), a schizophrenia susceptibility gene, is associated with risperidone treatment response. Our previous in vitro experiments confirmed that downregulated TNIK affected the effect of risperidone on downstream targets. However, the effect of downregulated TNIK on risperidone-induced molecular expression remains to be further explored. Transcriptome analysis was performed on U251 cells subjected to risperidone, TNIK siRNA, and no treatment, respectively. Compared to the no-treatment group, two groups of DEGs were screened out and then intersected with the schizophrenia-related genes to screen the cross-talk genes. Those DEGs were analyzed using GO and KEGG. STRING and Cytoscape were used to construct a protein-protein interaction (PPI) network for the cross-talk gene. The results showed that the parathyroid hormone synthesis, secretion, and action were significantly enriched after risperidone treatment. Downregulated TNIK could have an impact on the collagen-containing extracellular matrix, signaling receptor activator activity, and PI3K-Akt signaling pathway. Interestingly, bone mineralization function and calcium signaling pathway were enriched in the cross-talk genes. Additionally, FGFR2, FGF1, and FGFR might be the potential targets for TNIK affecting the effects of risperidone. The study indicated that risperidone primarily influences functions and/or pathways associated with bone metabolism, potentially contributing to the adverse effect of osteoporosis. Our study may offer a novel perspective on investigating the mechanisms underlying the adverse effects of risperidone.

Antioxidant Functions of Vitamin D and CYP11A1-Derived Vitamin D, Tachysterol, and Lumisterol Metabolites: Mechanisms, Clinical Implications, and Future Directions.

Evidence is increasing that vitamin D and CYP11A1-derived vitamin D, tachysterol, and lumisterol metabolites play a significant antioxidant role beyond its classical functions in bone health and calcium metabolism. Several recent studies have linked these elements to reduced oxidative stress as well as improved immune, cardiovascular, and neurological functions as a result of chronic kidney disease and cancer. Additionally, supplementation with this vitamin has been shown to be one of the most cost-effective micronutrient interventions worldwide, highlighting its potential as a therapeutic approach. The underlying mechanisms and implications of this antioxidant function of vitamin D or CYP11A1-derived vitamin D, tachysterol, and lumisterol metabolites are not well understood. This comprehensive and narrative review is aimed at summarizing the current evidence regarding the molecular mechanisms implicated in this antioxidant function of vitamin D, as well as to provide a general overview and to identify key research areas for the future, offering an extensive perspective that can guide both researchers and clinicians in the management of diseases associated with oxidative stress and/or insufficient vitamin D status.

The relationship between obstructive sleep apnea syndrome severity and vitamin D levels in sera

Aims: Obstructive Sleep Apnea Syndrome (OSAS) is a disorder characterized by complete or partial upper airway obstruction episodes and frequently decreased arterial oxygen saturation. Etiological factors and risk factors of OSAS are still investigated and studies in this topic continue. Until recently, researches were focused on the major effects of vitamin D on the bone metabolism and calcium homeostasis. Today; it has been found that vitamin D plays roles in many cells and tissues of human body additional to its functions in the musculoskeletal system. In our study, we aimed to examine vitamin D levels in patients who are diagnosed as OSAS and to investigate the relationship between OSAS and vitamin D deficiency. Methods: 83 volunteers, who were suspected to have OSAS, were included in the study. They all underwent polysomnography (PSG) in the Sleep Disorders Center in Pulmonary Department, between January 2015 – May 2015. Twenty cases with apnea hypopnea index (AHİ) &lt; 5/hour were evaluated as simple snoring/control group. Cases with AHİ &gt; 5/hour were diagnosed as OSAS; 22 patients were diagnosed as mild, 20 patients were diagnosed as moderate and 21 patients were diagnosed as severe OSAS. Blood samples of these patients were studied for the measurement of vitamin D [25(OH)D3], parathormone (PTH) , calcium (Ca), phosphor (P) levels and the samples were quickly delivered to biochemistry laboratory Results: A statistically significant difference in vitamin D levels were observed (p&lt;0.05) between the control and OSAS groups. However, no statistically significant difference was found in PTH, Ca, P levels among these groups (p&gt;0.05). Vitamin D levels in the control group were significantly higher than the mild and the severe OSAS patients. No statistically significant difference was observed in PTH, Ca, P levels between these patients. Conclusion: Our study indicates that there is a significant relationship between vitamin D deficiency and OSAS. This finding suggests that vitamin D deficiency may play a role in the OSAS physiopathology. There are few studies exists about the association between vitamin D deficiency and OSAS. In this regard, we think our study will contribute to the literature. Moreover; prospective, randomized, controlled studies with large series were needed.

Convergent synthesis, kinetics and computational attributions of indole-N-phenyltriazole hybrids bearing N-(aryl)butanamides as alkaline phosphatase inhibitors

In the research delineate herein, an innovative sequence of new series of multi-functional target molecules (9a-i) having indole-N-phenyltriazole bi-heterocyclic hybrids unified with N-arylated butanamides was synthesized as alkaline phosphatase inhibitor. The structural validation of all the formulated compounds was accomplished through IR, EI-MS, 1H NMR, 13C NMR and CHN analysis data. The in vitro enzyme inhibitory investigation revealed the efficacy of these bi-heterocyclic derivatives, 9a–i, as potent inhibitors of alkaline phosphatase relative to the standard used. The compound 9h was found to be the most active compound (IC50 = 0.062 ± 0.017 μM), and its inhibitory activity is about 10 times higher than potassium dihydrogen phosphate (KH2PO4) (IC50 = 5.251 ± 0.468 μM). The kinetics mechanism was attributed by evaluating the Lineweaver–Burk plots, which revealed that compound 9h inhibited the alkaline phosphatase non-competitively to form an enzyme–inhibitor complex. The inhibition constant Ki determined from Dixon plots for this compound was 0.045 μM. The computational study was in full agreement with the experimental records and these ligands exhibited good interactions and binding energy values. These molecules also demonstrated mild cytotoxicity toward red blood cell membranes when analyzed through hemolysis. So, based on the presented results, these molecules, being the promising inhibitors of alkaline phosphatase, might be deliberated as suitable medicinal scaffolds to render normal calcification of bones and teeth.

Utilization of cow bone waste and calcium oxide for the solidification and stabilization of MSWI fly ash: Towards sustainable practices

The quest for sustainable waste management practices has catalysed the development of innovative approaches to transform waste into resourceful products. This study explores the effectiveness of cow bone waste and calcium oxide (CaO) as agents in the stabilization/solidification (S/S) process of Municipal Solid Waste Incineration (MSWI) fly ash derived from two distinct cities employing both grate-type and circulating fluidized bed incinerators in China. Employing a robust experimental framework, the research evaluated the stabilization efficacy for heavy metals, monitored the progression of pH, and quantified the compressive strength of the treated MSWI fly ash. Moreover, it conducted risk assessment and economic analyses. Incorporating CBW and CaO into the MSWI fly ash from grate-type incinerators significantly enhanced the Pb stabilization efficiency, achieving up to 99.7 % when adding 31 % CBW and 7 % CaO. This treatment resulted in the leaching of other heavy metals, which were also below the standard landfill limits. In the circulating fluidized bed incinerator fly ash, the leaching concentrations of heavy metals in the treated samples were reduced by up to 98.6 % for Cd and 64.4 % for Ni.Additionally, an increase in CaO content was found to substantially improve the compressive strength of the solidified samples across all tested curing periods (7, 14, and 28 days). The optimal compressive strength result, observed at 28 days, reached 1.2 MPa, compared to the raw fly ash, which exhibited only 0.77 MPa when adding just 9 % CaO. This highlights CaO's critical role in enhancing the mechanical integrity of the treated MSWI fly ash. The study concludes that strategically calibrated ratios of cow bone waste and CaO attenuate the environmental hazard presented by MSWI fly ash and bolster its mechanical attributes, thereby repurposing the waste into a viable material for construction.

Bone regeneration driven by a nano-hydroxyapatite/chitosan composite bioaerogel for periodontal regeneration.

The most recent progress in reconstructive therapy for the management of periodontitis and peri-implantitis bone defects has relied on the development of highly porous biodegradable bioaerogels for guided bone regeneration. The objective of this work was to evaluate in vitro the osteoinduction of periodontal-originating cells (human dental follicle mesenchymal cells, DFMSCs) promoted by a nano-hydroxyapatite/chitosan (nHAp/CS) bioaerogel, which was purified and sterilized by a sustainable technique (supercritical CO2). Moreover, the in vivo bone regeneration capacity of the nHAp/CS bioaerogel was preliminarily assessed as a proof-of-concept on a rat calvaria bone defect model. The quantification of DNA content of DFMSCs seeded upon nHAp/CS and CS scaffolds (control material) showed a significant increase from the 14th to the 21st day of culture. These results were corroborated through confocal laser scanning microscopy analysis (CLSM). Furthermore, the alkaline phosphatase (ALP) activity increased significantly on the 21st day, similarly for both materials. Moreover, the presence of nHAp promoted a significantly higher expression of osteogenic genes after 21days when compared to CS scaffolds and control. CLSM images of 21days of culture also showed an increased deposition of OPN over the nHAp/CS surface. The in vivo bone formation was assessed by microCT and histological analysis. The in vivo evaluation showed a significant increase in bone volume in the nHAp/CS test group when compared to CS and the empty control, as well as higher new bone formation and calcium deposition within the nHAp/CS structure. Overall, the present study showed that the nHAp/CS bioaerogel could offer a potential solution for periodontal and peri-implant bone regeneration treatments since the in vitro results demonstrated that it provided favorable conditions for DFMSC proliferation and osteogenic differentiation, while the in vivo outcomes confirmed that it promoted higher bone ingrowth.

Evaluation of the elemental composition and radiological density of bone tissue when replacing a metaphyseal defect with bioceramic phosphate-silicate granules (experimental study)

Background: It is known that bioceramic implants containing various calcium or silicon compounds in isolation demonstrate osteoconductive effect in the replacement of post-traumatic bone defects. The combined use of these elements in single material should potentiate the organotypic filling of the bone cavity by creating favorable ion microenvironment and staged biodegradation. AIM: To identify the correlation of radiological indicators of the density of newly formed bone tissue and content of micro- and macronutrients in a bone defect when it is replaced by bioceramics with various mass ratio of calcium phosphate and silicate. MATERIALS AND METHODS: The study was performed on male rabbits of the “white giant” breed, which, after receiving a standardized delimited metaphysical bone defect, implants with variable ratio of calcium phosphate and calcium silicate (in proportions of 40/60, 50/50 and 60/40 wt. %) were used to replace it. The results were evaluated using multispiral computed tomography and scanning electron microscopy energy dispersive analysis with detection by the method of correlation analysis of possible connections between the obtained data. RESULTS: Quantitative indicators of calcium and phosphorus content in bone regenerate in all groups increased mainly in the period from 30 to 60 days, and silicon content, reaching maximum amounts by the 30th day of the experiment, subsequently decreased monotonously, which showed participation of this element in the starting regenerative processes, and its decrease served as a marker of organotypic restructuring. In the elemental analysis of newly formed bone tissue during implantation of bioceramics containing phosphate and calcium silicate in the proportion of 60/40 wt. %. The highest amounts of calcium, phosphorus and silicon and the highest density of newly formed bone tissue were noted, which had direct correlation, and this pattern was observed both in the early stages (30 days) and throughout the experimental study. CONCLUSION: Analyzing the data obtained, it can be concluded that it is advisable to study the features of the course of reparative osteogenesis depending on the ionic environment, as well as the high potential of using synthetic bioceramics in general and the prospects of using implants on the basis of phosphate-silicate composites for bone defects replacement.

Measurement of Vitamin D Level among Covid-19 Patients and its Correlation with Severity of the Disease

Abstract Background Coronavirus disease 2019 (covid-19) is defined as illness caused by a novel coronavirus now called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was first identified among an outbreak of respiratory illness cases in Wuhan City, China. Vitamin D is known to play a key role in the maintenance of bone health and calcium–phosphorus metabolism, yet many other functions of this vitamin have been recently postulated, such as modulation of the immune response in both infectious and autoimmune diseases. Different studies showed that severity of covid-19 infection is directly related to vitamin D level. Methods This is an observational cross-sectional study, which includes 80 COVID-19 patients, and admitted in the ward and ICU of EL Medany Hospital, EL Demerdash and EL Obour specialized hospital. All patients had positive PCR for COVID-19. Chest CT without contrast was done for all patients and categorized according to CORAD staging. Serum vitamin D level was measured, besides laboratory inflammatory markers (CRP, ferritin, d-dimer), kidney and liver function tests, and complete blood picture. Results Our study included 80 patients; 33 males and 47 females with mean age of (51±10.5 years). Measured Vitamin D level range was (10±9 ng/mL). It was found that male patients had higher level of serum vitamin D (12.6±8.6 ng/mL) than female patients (11.5±9.5 ng/mL) but with no statistically significant difference. The commonest presentations were sore throat (97.5%), and fever (93.75%). COVID-19 patients presenting with cough and fever had highly significantly lower levels of vitamin D than patients not presenting by these symptoms (P-value 0.006, 0.032) respectively. In the current study, patients with CORAD 5 in chest CT had the lowest vitamin D level (9.6±7.8 ng/mL), compared to patients with CORAD 3 (13.6±9.7 ng/mL), and CORAD 4 (11.8 ±8.8 ng/mL). According to the correlation analysis, a decrease in vitamin D levels was associated with more severe COVID-19 cases, with significantly higher blood levels of inflammatory markers CRP and ferritin (P-value 0.02, 0.01). No correlation was found between vitamin D levels and hemoglobin level, white cell count, platelet count, or D-Dimer. Conclusion Our findings suggest that the COVID-19-positive individuals with lower vitamin D levels, had significantly higher blood levels of inflammatory markers (Ferritin and CRP), and increased frequencies of ground-glass opacity appearance in chest CT scans. Accordingly, vitamin D deficiency may be a marker of poor prognosis in COVID-19 patients.

Effect of Caponization on Blood Parameters and Tibia Characteristics in Crossbred Chickens Derived from Conserved Breed Hens and Meat Roosters

Abstract The effect of caponization on the level of testosterone, biochemical bone markers as well as on the geometrical, densitometric, structural, mechanical and microstructural characteristics of the tibia of capons was the subject of this study. The study was conducted on 80 hybrids obtained from the crossing of Rhode Island Red (R-11) hens and meat roosters (Ross 308). Cockerels were surgically castrated at 8 week of age and then fattened until the 24th week of life. The results indicated that the serum testosterone (P&lt;0.01), osteocalcin (P&lt;0.05), and osteoprotegerin (OPG) (P&lt;0.05) concentration were significantly lower, while the serum receptor activator of nuclear factor kappa-B ligand (RANKL) (P&lt;0.01), RANKL/OPG ratio (P&lt;0.05) and alkaline phosphatase concentrations (P&lt;0.05) were significantly higher in capons. The tibia weight, the relative tibia weight, and the cross-sectional area of tibia were significantly higher (P&lt;0.05) in cockerels, while capons had higher (P&lt;0.05) body weight and transversal external diameter of tibia. Moreover, the bone ash, calcium and phosphorus content, bone mineral density and bone mineral content, and also yield load, ultimate load, work to fracture, as well as Young’s modulus, bending moment, yield stress and ultimate stress were significantly lower (P&lt;0.05) in capons. Caponization also caused a significant reduction in the percentage volume of bone (P&lt;0.05) in the proximal epiphyses of the tibia, as well as changes in its microarchitecture (P&lt;0.05) (fewer trabeculae and connections between trabeculae, thicker trabeculae and larger spaces between trabeculae). Concluding, caponization disrupts the homeostasis and microstructure of the tibia, and this results in a decrease in the mechanical strength of the tibia, making it more susceptible to deformation.

Zinc Action in Vascular Calcification.

Although zinc's involvement in bone calcification is well-established, its role in vascular calcification, characterized by abnormal calcium and phosphorus deposition in soft tissues and a key aspect of various vascular diseases, including atherosclerosis, remains unclear. This review focuses on zinc's action in vascular smooth muscle cell (VSMC) calcification, including the vascular calcification mechanism. Accumulated research has indicated that zinc deficiency induces calcification in VSMCs and the aorta, primarily through apoptosis accompanied by a downregulation of smooth muscle cell markers. Moreover, zinc deficiency-induced vascular calcification operates independently of the action of alkaline phosphatase (ALP) activity, typically associated with osteogenic processes, but is partly regulated via inorganic phosphate transporter-1 (Pit-1). To date, research has shown that zinc regulates vascular calcification through a mechanism distinct from that of osteogenic calcification, providing insight into its dual effects on physiological and pathological calcification and thereby explaining the "zinc paradox," wherein zinc simultaneously increases osteoblastic calcification and decreases VSMC calcification.

Adequate Levels of Zinc and Copper on Turkey Poult Performance, Immunological Response, and Skeletal Health.

In this study, the impact of varying dietary zinc (Zn) and copper (Cu) levels on the growth, immunological response, and skeletal health of developing turkey poults was investigated. For 0-4 and 5-8 weeks of age, respectively, three Zn levels of 50, 70, and 90mg/kg and 45, 65, and 85mg/kg were employed. Three Cu levels, namely 8, 12, and 16mg/kg for 0-8 weeks of age, were also utilized. There were 288 (9 × 4 × 8) day-old turkey poults with equal body weight that were randomly assigned to 9 treatments, each consisting of 4 replicates and 8 poults per replicate. In comparison to other dietary combinations, there was a significant (P ≤ 0.05) increase in body weight gain observed in the 90 and 85mg Zn/kg with 16mg Cu/kg diet during 0-4 and 0-8 weeks of age, respectively, and the 70 and 65mg Zn with 16mg Cu /kg diet during 0-4 and 0-8 weeks of age, respectively. When compared to low levels of zinc in the diet at 5-8 and 0-8 weeks of age, respectively, feed conversion ratio was shown to be significantly (P ≤ 0.01) better with 90 and 85mg Zn/kg diet. In a similar pattern, feed utilization efficiency was considerably (P ≤ 0.01) higher at 16mg Cu/kg diet than it was at lower Cu levels in the diets given to the animals over the 0-4 week period. Compared to other dietary combinations, there was a substantial (P ≤ 0.01) improvement in cell-mediated immune response (foot web index to PHAP) and humoral immune response (HA titer to SRBC) when 85mg zinc and 16mg copper/kg diet was consumed at 0-4 and 5-8 weeks of age. At greater dietary Zn and Cu levels than its lower values, the weight of the spleen and thymus was considerably (P ≤ 0.05) higher. In a dietary combination of 90mg Zn with 16mg Cu/kg during 0-4 and 85mg Zn with 16mg Cu/kg diet during 5-8 weeks of age, respectively, there were significantly (P ≤ 0.05) greater bone width (proximal and distal), tibia bone ash, calcium, and phosphorus detected respectively. Significantly (P ≤ 0.01) greater Zn and Fe contents were found in the tibia bone at 90 and 85mg Zn/kg diet, respectively, compared to values obtained at other Zn levels in the diet throughout 0-4 and 5-8 weeks of age. During the first 8 weeks of life, a diet containing 12mg of copper per kilogram was shown to have a significantly (P ≤ 0.05) increased Zn and Fe content in the tibia bone compared to other levels. It is possible to draw the conclusion from the data that, for growing turkey poults, dietary combinations of 90mg Zn/kg with 16mg Cu/kg diet and 85mg Zn with 16mg Cu/kg diet between 0 and 4 and 5-8 weeks of age, respectively, were sufficient for optimum development, immunity, and skeletal health indices.